Skip to main content

Table 1 Sample Characteristics

From: Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Sample Characteristics
N = 22
Frequency
(%)
Age at diagnosis
 18–44 years
 45–60 years 11 (50)
 60–79 years 11 (50)
Lymph Node Status
 Positive 10 (45)
 Negative 12 (55)
Hormone Status
 ER+ 22 (100)
 PR+ 16 (73)
 Her2+ 2 (9)
Treatment History
 Surgery 22 (100)
 Chemotherapy 9 (41)
 Radiation 18 (82)
AET Use
 Tamoxifen only 7 (32)
 AI only 5 (23)
 Both tamoxifen and AI 9 (41)
 Did not initiate 1 (5)
Persistence
 Non-persistent 6 (27)
 Did not initiate 1 (5)
 Persistent 15 (68)
Average Perceived Risk of Breast Cancer Recurrence (0–100%)
 Non-persistent/did not initiate 33%
 Persistent 29%